Ketryx logo — Develop fast. Stay compliant.

Ketryx

Develop fast. Stay compliant.

Founded 2021 United States Cambridge, United States 145 employees Series B Total: $57.05M Information Technology, Internet

General Information

Company Name Ketryx
Founded Year 2021
Location United States Cambridge, United States
Employees 145
Industries Information Technology, Internet
Funding Stage Series B
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Tiered Pricing, Consulting Fee
Social

BounceWatch is an independent company data service, not affiliated with Ketryx. To contact Ketryx, visit ketryx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ketryx compare?

A PDF of Ketryx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ketryx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Ketryx

Ketryx, founded in 2021, is an American startup specializing in Information Technology and the Internet. The company is on a mission to revolutionize the product lifecycle management for regulated industries, particularly focusing on medical devices. Prominently known for their slogan, "Develop fast. Stay compliant," Ketryx is trusted by four of the world’s top five medical device manufacturers.

Through its AI-native compliance platform, Ketryx automates documentation processes, enhances traceability, and expedites release cycles without altering existing workflows. Their AI Agents significantly reduce manual effort by 90%, thus closing compliance gaps and enhancing both speed and quality in product deliveries.

Having raised a $39.00M Series B investment on 01 September 2025, Ketryx is backed by prominent investors such as E14 Fund, Lightspeed Venture Partners, Transformation Capital, Ubiquity Ventures, and Fifty Three Stations, underscoring their potential to make impactful strides in their sector.

Business keywords: AI-native compliance platform, Medical device compliance, Product lifecycle management, Regulated software development, Automated documentation, Traceability, Risk management, Quality management system, IEC 62304, FDA compliance, ISO 13485, ISO 14971, 21 CFR Part 11, V-Model, eQMS

Services & Products

AI-native compliance for medical applications
Accelerating AI/ML software development
Compliance integration into existing development tools
Automated requirements and risk traceability
Automated documentation and report generation
AI-powered change impact assessment

Target Customers

Medical Device Manufacturers Life Sciences Teams AI/ML Product Teams Quality Assurance Teams Regulatory Affairs Teams R&D Teams

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $39.00M 5
E14 Fund, Lightspeed Venture Partners +3
01 Sep 2025
Series A $14.00M 3
E14 Fund, Lightspeed Venture Partners +1
01 Dec 2023
Early VC $2.00M -
01 Jun 2022
Seed $2.05M -
01 Nov 2021

Ketryx Alternatives & Competitors

View All Alternatives
Ketryx vs
IntellaQuest
IntellaQuest United States

The Integrated and Modular Business Operating System for all your Business Process Workflows

49 employees
Information Technology, Internet
Ketryx vs

Most secure B2B tool for sending and receiving files with traceability and advanced security feature...

Venture round
26 employees
Information Technology, Internet
Ketryx vs
mesur.io
mesur.io United States

Helping enterprises identify supply chain risks before they happen

Non Equity Assistance
26 employees
Analytics, Information Technology

FAQ About Ketryx

Develop fast. Stay compliant.
Ketryx was founded in 2021.
Ketryx is headquartered in Cambridge, United States.
Ketryx operates in Information Technology and Internet. Its work centres on AI-native compliance platform, Medical device compliance, Product lifecycle management and Regulated software development. Its customers include Medical Device Manufacturers, Life Sciences Teams and AI/ML Product Teams.
Ketryx has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Tiered Pricing and Consulting Fee.
Ketryx has approximately 145 employees.
Ketryx has completed 4 funding rounds, raising a total of $57.05M. The latest funding stage is Series B.
Ketryx offers: AI-native compliance for medical applications, Accelerating AI/ML software development, Compliance integration into existing development tools, Automated requirements and risk traceability, Automated documentation and report generation, AI-powered change impact assessment.
Top alternatives and competitors to Ketryx include IntellaQuest, Tranxfer, mesur.io, StrategyBlocks, Eunomart. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ketryx and IntellaQuest are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ketryx, https://bouncewatch.com/company/ketryx, updated 24 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes